ArticleClinical kidney journal2023

The open system of FGF-23 at the crossroad between additional P-lowering therapy, anemia and inflammation: how to deal with the intact and the C-terminal assays?

Lorenza Magagnoli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.